Cargando…
Intra-Arterial Glycoprotein IIb/IIIa Inhibitor Treatment for Symptomatic Intracranial Atherosclerotic Stenosis Presenting as Large Vessel Occlusions
Introduction There is no consensus on the optimal treatment for acute ischemic stroke (AIS) large vessel occlusions (LVOs) or near-occlusions with underlying intracranial atherosclerotic stenosis (ICAS). We report the first American series using intra-arterial (IA) glycoprotein IIb/IIIa inhibitors (...
Autores principales: | Srivatsan, Aditya, Srinivasan, Visish M, Chen, Stephen, Kan, Peter, Johnson, Jeremiah N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430682/ https://www.ncbi.nlm.nih.gov/pubmed/32821589 http://dx.doi.org/10.7759/cureus.9243 |
Ejemplares similares
-
Stroke recurrence is associated with unfavorable intracranial venous outflow in patients with symptomatic intracranial atherosclerotic large vessel severe stenosis or occlusion
por: Gao, Jiali, et al.
Publicado: (2023) -
Detection of High-Risk Atherosclerotic Plaques with Ultrasound Molecular Imaging of Glycoprotein IIb/IIIa Receptor on Activated Platelets
por: Guo, Shengcun, et al.
Publicado: (2015) -
Absence of platelet membrane glycoproteins IIb/IIIa from monocytes
Publicado: (1985) -
The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
por: Kaluski, Edo
Publicado: (2008) -
Endovascular Treatment of Acute Stroke Due to Intracranial Atherosclerotic Stenosis–Related Large Vessel Occlusion
por: Park, Hyungjong, et al.
Publicado: (2019)